16 July 2025 - Multinational conglomerate Pfizer has accused the PBS of “under­valuing” medical products in a submission to the Productivity Commission, echoing the push by American pharmaceutical lobbyists for the subsidy program to be targeted in tariff negotiations.

The PBS provides discounted drugs based on the advice of independent assessors who test the cost-efficiency of products against other offerings approved in the Australian market.

It came under increased pressure from the Pharmaceutical Research and Manufacturers of America following the election of Donald Trump.

Read The Australian article